~~<i id='489EAA98C0'><strike id='489EAA98C0'><tt id='489EAA98C0'><pre id='489EAA98C0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

hotspot

author：focus 2025-09-27 10:01:44 - browse：4

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Biotech reporter’s notebook: A sunnier mood at JPM 2024

Wikipedia

hotspot

focus

leisure time

FILE-CaliforniaGov.GavinNewsomspeaksatanewsconferenceinSacramento,Calif.,onMarch16,2023.Newsomhadthr

WSS

Russian special forces kill a gunman who broke into a private house near Moscow

New menopause drug shows promise in relief for hot flashes

Body of missing toddler recovered in Delaware River days after flood: Police

Will.i.am, Britney Spears release new single, 'Mind Your Business'

JPM 2024: Verve Therapeutics looks to mainstream genome editing

Risky weight loss products often used by teens globally, per study

Wikipedia

hotspot

Wikipedia

How one medical school became remarkably diverse

Artificial intelligence advances fuel industry trying to preserve loved ones after death

In age of alternative facts, a scholarly course on calling out crap

JPM 2024: Verve Therapeutics looks to mainstream genome editing

In Memoriam: Notable people who died in 2023

Court strikes down limits on filming of police in Arizona

Supreme Court strikes down use of affirmative action

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

Sports medicine is finally prioritizing gender equality

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Wikipedia

Death toll from an explosion and collapse of a Paris building in June climbs to 3

As Taiwan prepares for anti

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

7 of the most gruesome medical devices in history

Review: 'Barbie' will hit you like a shot in the heart

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

hotspot

focus

focus

leisure time